The FLASCO Clinical Oncology Series: Antibody-Drug Conjugates (ADCs) is an advanced educational program designed to explore the groundbreaking role of antibody-drug conjugates in modern cancer therapy. This series will provide healthcare professionals with a comprehensive understanding of how ADCs are revolutionizing the treatment landscape, targeting cancer cells with precision while minimizing toxicity to healthy tissues….